Sysmex (OTCMKTS:SSMXY) Updates FY 2024 Earnings Guidance

Sysmex (OTCMKTS:SSMXY) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 0.580-0.580 for the period. The company issued revenue guidance of $3.3 billion-$3.3 billion.

Sysmex Price Performance

OTCMKTS SSMXY opened at $18.22 on Wednesday. Sysmex has a 1 year low of $14.38 and a 1 year high of $28.58. The company has a market cap of $11.47 billion, a price-to-earnings ratio of 36.91 and a beta of 0.90. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.19 and a quick ratio of 2.42. The stock’s fifty day moving average price is $18.92 and its 200 day moving average price is $19.02.

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share for the quarter. As a group, equities research analysts forecast that Sysmex will post 0.57 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.